Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease. [electronic resource]
- Coronary artery disease Nov 2013
- 542-8 p. digital
Publication Type: Comparative Study; Journal Article; Observational Study
1473-5830
10.1097/MCA.0b013e328363abbd doi
Aged Cerebrovascular Disorders--mortality Cilostazol Coronary Restenosis--mortality Coronary Stenosis--diagnosis Coronary Thrombosis--mortality Drug Therapy, Combination Drug-Eluting Stents Female Hemorrhage--chemically induced Humans Kaplan-Meier Estimate Male Middle Aged Multivariate Analysis Myocardial Infarction--mortality Percutaneous Coronary Intervention--adverse effects Platelet Aggregation Inhibitors--adverse effects Proportional Hazards Models Registries Republic of Korea Retrospective Studies Risk Factors Tetrazoles--therapeutic use Time Factors Treatment Outcome